24 maj: Torsdagens obligationer: Rutsjetur endte med et lille rentehop
24 maj: Danmark/Nationalbanken: Renten kan blive negativ - bureau
24-05-2012 17:05:00

Announcement of transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associate

Relateret indhold
11 maj - 
Onsdagens aktier: Carlsberg faldt tungest i C20-dyk ..
11 maj - 
Aktier/middag: Carlsberg forrest i C20-nedtur - Lundbec..
11 maj - 
Aktier/åbning: Lundbeck skyder frem - C20 vipper omkrin..
Relateret debat
11 maj - 
Generelt synes jeg sektoren ser mere og mere interessan..
10 maj - 
Hvis ellers det øvrige marked arter sig og de opfører s..
10 maj - 
er der nogen der har en fornemmelse hvor vi lander i l&..

H. Lundbeck A/S hereby reports transactions made by executives and persons and

legal entities closely associated to them with shares in H. Lundbeck A/S and

linked securities, cf. section 28a of the Danish Securities Trading Act.

The list is based on reports received by H. Lundbeck A/S from the company's

executives today or yesterday.

Name: Anders Gersel Pedersen

Job position of the Executive Vice President &

executive: Head of Research & Development

ID code (ISIN code): DK 0010287234

Description of the Share

security:

Nature of the transaction: Transferred as part of Lundbeck’s Long Term

Incentive Program for Executive Management

Date of trading: 23 May 2012

Market on which the Nasdaq OMX Copenhagen

trading was effected:

Number of traded 33,583 shares

securities:

Persons or entities under an obligation to report are defined as members of the

Executive Management and the Supervisory Board of H. Lundbeck A/S and

persons/entities closely associated to them.

Closely associated persons/entities means inter alia:

-- spouse or cohabitant

-- children below the age of 18

-- legal entities in which the insider has a controlling influence

The content of this release will have no influence on the Lundbeck Group’s

financial expectations for 2012.

Lundbeck contacts

Investors: Media:

Palle Holm Olesen Mads Kronborg

Chief Specialist, Head of Investor Relations Media Relations Manager

palo@lundbeck.com mavk@lundbeck.com

+45 36 43 24 26 +45 36 43 28 51

Magnus Thorstholm Jensen Simon Mehl Augustesen

Investor Relations Officer International Media Specialist

matj@lundbeck.com smeh@lundbeck.com

+45 36 43 38 16 +45 36 43 49 80

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is an international pharmaceutical

company highly committed to improving the quality of life for people suffering

from brain disorders. For this purpose, Lundbeck is engaged in the research,

development, production, marketing and sale of pharmaceuticals across the

world. The company’s products are targeted at disorders such as depression and

anxiety, psychotic disorders, epilepsy and Huntington’s, Alzheimer’s and

Parkinson’s diseases.

Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today

Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the

world’s leading pharmaceutical companies working with brain disorders. In 2011,

the company's revenue was DKK 16.0 billion (approximately EUR 2.1 billion or

USD 3.0 billion). For more information, please visit www.lundbeck.com.

Vedhæftet fil: Release no 471_1.pdf

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

USA-vind/dir: Svært at konkurrere mod de tre store

26-05-2016 14:48:02
Det amerikanske vindmøllemarked er domineret af de tre store mølleleverandører GE, Vestas og Siemens. Men gunstige markedsudsigter i flere år frem kan få nogle ..

GE-vindboss: 3 MW-platform meget succesfuld i Europa

25-05-2016 16:20:04
GE Renewable Energys administrerende direktør for onshoremøller, Anne McEntee, udtrykker stor tilfredshed med, hvordan markedet i Europa har taget i mod selskab..

Sanofi vil smide Medivations bestyrelse på porten

25-05-2016 13:38:02
Det franske medicinalselskab Sanofi, der konkurrerer med blandt andet danske Novo Nordisk, vil have skiftet bestyrelsen i amerikanske Medivation ud for at få en..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas/dir: Ordretravlhed forude på det amerikanske marked
2
Aktier/tendens: Rolig åbning mens olieprisen runder 50
3
Zealand Pharma: FDA anbefaler godkendelse af Iglarlixi
4
Pandora: Amerikansk forhandlers sammenlignelige salg falder-NY
5
USA-vind/dir: Svært at konkurrere mod de tre store

Relaterede aktiekurser

H Lundbeck A/S 262,60 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
27. maj 2016 06:26:01
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160526.2 - EUROWEB3 - 2016-05-27 06:26:01 - 2016-05-27 06:26:01 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x